涛生医药 (839411.OC)

+ 收藏

资产负债表(涛生医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 13,703,426.7216,119,094.9214,284,032.2113,905,675.90
 应收票据及应收账款(元) 42,977,441.4135,320,117.6551,415,281.8151,927,059.06
  其中:应收账款(元) 42,977,441.4135,320,117.6551,415,281.8151,927,059.06
 预付款项(元) 6,849,795.6611,874,113.1810,633,946.389,812,129.49
 其他应收款(元) 3,595,661.065,028,126.227,522,515.158,858,488.62
 存货(元) 5,061,556.754,885,350.546,417,790.437,070,821.42
 其他流动资产(元) 4,831,129.073,472,167.061,957,546.381,596,200.35
 流动资产合计(元) 77,019,010.6776,698,969.5792,231,112.3693,170,374.84
非流动资产:
 固定资产(元) 19,405,887.0219,043,991.4120,334,329.2821,379,566.39
 在建工程(元) 55,245,853.8233,790,916.4216,459,081.471,978,520.58
 使用权资产(元) 318,976.06190,970.902,193,205.952,988,166.83
 无形资产(元) 12,507,381.2412,676,381.519,400,331.447,573,738.32
 开发支出(元) 12,362,664.7510,567,642.6813,536,005.4512,947,850.76
 商誉(元) ---127,594.81
 长期待摊费用(元) 622,239.98739,494.141,611,762.551,729,428.71
 递延所得税资产(元) 1,937,095.332,929,755.683,974,775.963,483,954.70
 非流动资产合计(元) 102,400,098.2079,939,152.7467,509,492.1052,208,821.10
资产总计(元) 179,419,108.87156,638,122.31159,740,604.46145,379,195.94
流动负债:
 短期借款(元) 43,000,000.0034,172,878.8926,158,694.4420,006,423.09
 应付票据及应付账款(元) 17,660,041.568,182,571.0131,362,287.5322,680,993.13
  其中:应付票据(元) --2,155,581.363,982,814.36
  其中:应付账款(元) 17,660,041.568,182,571.0129,206,706.1718,698,178.77
 合同负债(元) 14,168,874.6010,490,984.0114,324,081.019,305,254.30
 应付职工薪酬(元) 1,616,225.101,167,028.531,205,259.88763,565.37
 应交税费(元) 530,326.9169,041.09241,129.13118,582.79
 其他应付款(元) 11,102,846.8620,186,093.321,830,023.463,024,519.22
 一年内到期的非流动负债(元) -4,400,000.0013,200,000.009,300,712.38
 其他流动负债(元) 1,841,954.371,363,827.921,862,130.531,209,683.06
 流动负债合计(元) 89,920,269.4080,032,424.7790,183,605.9866,409,733.34
非流动负债:
 长期借款(元) 13,206,250.019,400,000.002,504,102.8011,884,102.80
 租赁负债(元) 340,423.19219,950.962,394,765.243,065,270.41
 递延所得税负债(元) 79,744.02---
 非流动负债合计(元) 13,626,417.229,619,950.964,898,868.0414,949,373.21
负债合计(元) 103,546,686.6289,652,375.7395,082,474.0281,359,106.55
所有者权益(或股东权益):
 实收资本或股本(元) 66,503,300.0066,503,300.0066,503,300.0066,503,300.00
 资本公积(元) 29,986,131.0630,445,189.3830,445,189.3827,717,561.27
 盈余公积(元) 1,050,846.721,050,846.721,050,846.721,050,846.72
 未分配利润(元) -54,860,833.42-47,872,329.45-49,236,503.78-37,440,307.99
 归属于母公司股东权益合计(元) 42,679,444.3650,127,006.6548,762,832.3257,831,400.00
 少数股东权益(元) 33,192,977.8916,858,739.9315,895,298.126,188,689.39
 股东权益合计(元) 75,872,422.2566,985,746.5864,658,130.4464,020,089.39
负债和股东权益合计(元) 179,419,108.87156,638,122.31159,740,604.46145,379,195.94
公告日期 2024-04-242023-08-282023-04-142022-08-24
审计意见(境内) 带强调事项段的无保留意见带强调事项段的无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院